$TNON

Tenon Medical Inc. (NASDAQ: TNON) shares surged 53.64% after repaying $5.16M in convertible notes, reducing debt risk. The company reported Q2 2026 revenue of $1.3M, up 127% YoY, with a 64% gross margin. Despite strong growth, TNON faces financial challenges, including a $4.05M net loss and negative equity. Traders are monitoring the stock due to its volatility and recent catalysts, such as FDA clearance and increased surgical volume.

Tenon Medical (TNON) repaid $5.16M in notes, strengthening its balance sheet. AEON Biopharma (AEON) reported positive study results for ABP-450. Silexion (SLXN) announced September conference participations. Orchestra BioMed (OBIO) and Indaptus (INDP) also shared updates, with shares rising.

Tenon Medical (NASDAQ:TNON) shares rose 23.77% in after-hours trading after repaying $5.16M in convertible notes early, reducing dilution risk. The company develops devices for sacroiliac joint disorders. Its market cap is $1.63M, with a 52-week range of $2.40-$50.40. The stock closed at $2.44, down 27.38% on Wednesday.

Tenon Medical (NASDAQ:TNON) repaid $5.16M in convertible notes early, strengthening its balance sheet and avoiding potential share dilution. The company aims to maintain financial flexibility for growth and commercialization of its medical devices, according to its CEO.

HRT FINANCIAL LP purchased 1,658 shares of Tenon Medical, Inc. (TNON) at $3.98 on 2026-09-03.

HRT FINANCIAL LP purchased 1,790 shares of Tenon Medical, Inc. (TNON) at $4.57 on 2026-09-01.

HRT FINANCIAL LP purchased 18,357 shares of Tenon Medical, Inc. (TNON) at an average of $5.58 ($5.21–$6.35, $0.10M total) across 2 trades on 2026-08-28.

Tenon Medical, Inc. (TNON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Tenon Medical Announces Pricing of $3M Private Placement Offering LOS GATOS, CA – August 28, 2026 – Tenon Medical, Inc. (Nasdaq: TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that on A

Tenon Medical (NASDAQ: TNON) closed a $3M private placement offering, selling 597,610 shares and warrants. The offering price was $5.02 per share. WallachBeth Capital acted as the exclusive placement agent. The proceeds will be used for general corporate purposes, minus fees and expenses.

Tenon Medical (TNON) will sell 0.598 million shares of common stock or pre-funded warrants, plus warrants for 1.06 million shares, in a $3 million private placement. The offering is expected to close by August 31, 2026. TNON's stock is down 4.79% in pre-market trading.